THC Global Group Limited (ASX:THC), to be renamed Epsilon Healthcare Limited, is a diversified global high value pharmaceuticals and healthcare company with primary operations in Australia and Canada. THC Global is the first ASX listed entity to fully own and operate end to end commercial medicinal cannabis production facilities under Australia’s cannabis regulations. THC Global’s Southport Facility in Southport, Australia is one of the largest pharmaceutical GMP cannabis manufacturing facilities in the world. THC Global also owns and operates a fast growing turnkey cultivation solutions provider, including a hydroponics equipment and supplies wholesaler and retailer servicing the rapidly expanding cannabis sectors in North America and Europe.
THC Global Group Limited (ASX:THC), to be renamed Epsilon Healthcare Limited, is a diversified global high value pharmaceuticals and healthcare company with primary operations in Australia and Canada. THC Global is the first ASX listed entity to fully own and operate end to end commercial medicinal cannabis production facilities under Australia’s cannabis regulations. THC Global’s Southport Facility in Southport, Australia is one of the largest pharmaceutical GMP cannabis manufacturing facilities in the world. THC Global also owns and operates a fast growing turnkey cultivation solutions provider, including a hydroponics equipment and supplies wholesaler and retailer servicing the rapidly expanding cannabis sectors in North America and Europe.
Company Information
- Industry
- Pharmaceuticals
- Company Type
- Privately Held
- Founded
- unknown
- Employee Range
- 11-50
- Revenue Range
- Not available
Location
- Address
- 131 Macquarie St New South Wales Sydney
- City
- Sydney
- Region
- New South Wales
- Postal Code
- 2000
- Country
- Australia